Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-01-03

Clinical Trial Update: DISE in Pediatric Sleep Disordered Breathing [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial investigating DISE for pediatric sleep-disordered breathing has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Iowa | Conditions: Sleep Disordered Breathing, Drug Induced Sleep Disorder | Phase 2, Phase 3 | Status: WITHDRAWN